Logo image of LFVN

LIFEVANTAGE CORP (LFVN) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:LFVN - US53222K2050 - Common Stock

5.97 USD
+0.27 (+4.74%)
Last: 1/22/2026, 5:20:02 PM
5.97 USD
0 (0%)
After Hours: 1/22/2026, 5:20:02 PM

LFVN Key Statistics, Chart & Performance

Key Statistics
Market Cap75.76M
Revenue(TTM)228.88M
Net Income(TTM)10.13M
Shares12.69M
Float10.46M
52 Week High24.73
52 Week Low5.47
Yearly Dividend0.17
Dividend Yield2.84%
EPS(TTM)0.81
PE7.37
Fwd PE4.81
Earnings (Next)02-03
IPO2012-09-12
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
LFVN short term performance overview.The bars show the price performance of LFVN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

LFVN long term performance overview.The bars show the price performance of LFVN in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 -60

The current stock price of LFVN is 5.97 USD. In the past month the price decreased by -0.33%. In the past year, price decreased by -75.37%.

LIFEVANTAGE CORP / LFVN Daily stock chart

LFVN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LFVN Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to LFVN. LFVN scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LFVN Financial Highlights

Over the last trailing twelve months LFVN reported a non-GAAP Earnings per Share(EPS) of 0.81. The EPS increased by 35% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.43%
ROA 16.46%
ROE 30.56%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%20%
Sales Q2Q%0.73%
EPS 1Y (TTM)35%
Revenue 1Y (TTM)16.77%

LFVN Forecast & Estimates

8 analysts have analysed LFVN and the average price target is 14.79 USD. This implies a price increase of 147.74% is expected in the next year compared to the current price of 5.97.

For the next year, analysts expect an EPS growth of 36.87% and a revenue growth -1.21% for LFVN


Analysts
Analysts82.5
Price Target14.79 (147.74%)
EPS Next Y36.87%
Revenue Next Year-1.21%

LFVN Ownership

Ownership
Inst Owners64.34%
Ins Owners14.5%
Short Float %24.64%
Short Ratio14.58

About LFVN

Company Profile

LFVN logo image LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 232 full-time employees. The company went IPO on 2012-09-12. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. The company sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.

Company Info

LIFEVANTAGE CORP

3300 Triumph Blvd, Suite 700

Lehi UTAH 84043 US

CEO: Steven R. Fife

Employees: 222

LFVN Company Website

LFVN Investor Relations

Phone: 18014329000

LIFEVANTAGE CORP / LFVN FAQ

What does LFVN do?

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 232 full-time employees. The company went IPO on 2012-09-12. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. The company sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.


What is the current price of LFVN stock?

The current stock price of LFVN is 5.97 USD. The price increased by 4.74% in the last trading session.


Does LFVN stock pay dividends?

LIFEVANTAGE CORP (LFVN) has a dividend yield of 2.84%. The yearly dividend amount is currently 0.17.


What is the ChartMill technical and fundamental rating of LFVN stock?

LFVN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


Can you provide the PE ratio for LFVN stock?

The PE ratio for LIFEVANTAGE CORP (LFVN) is 7.37. This is based on the reported non-GAAP earnings per share of 0.81 and the current share price of 5.97 USD.


Can you provide the upcoming dividend date for LIFEVANTAGE CORP?

The next ex-dividend date for LIFEVANTAGE CORP (LFVN) is December 1, 2025.


What is the employee count for LFVN stock?

LIFEVANTAGE CORP (LFVN) currently has 222 employees.